BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Advanced Therapies Wales - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://advancedtherapieswales.co.uk
X-WR-CALDESC:Events for Advanced Therapies Wales
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260311T090000
DTEND;TZID=Europe/London:20260311T170000
DTSTAMP:20260507T185758
CREATED:20260109T133600Z
LAST-MODIFIED:20260109T133600Z
UID:468-1773219600-1773248400@advancedtherapieswales.co.uk
SUMMARY:Unlocking TIL Therapy: A New Era for Melanoma Care in the UK
DESCRIPTION:TIL (Tumour-Infiltrating Lymphocyte) therapy is a transformative\, cell-based immunotherapy approach now entering clinical practice for melanoma. This national summit brings together UK and international leaders to share the science\, clinical experience\, and infrastructure required to implement TIL therapy safely and effectively. From the biological rationale to real-world delivery\, the day explores how academic\, clinical\, and industry partners can work together to make TIL therapy accessible for patients across the UK. \nIntended Audience\nClinical Staff (including Clinical/ Medical Oncologists Surgeons\, Haematologists\, Pathologists\, radiologists)\, Scientists\, Translational Researchers\, NHS Policymakers and those who have an interest in this field. \nWhat to expect\n– Recognise how biomarkers and the tumour microenvironment predict TIL response\n– Understand the core science and clinical development of TIL therapy\n– Learn key factors in patient selection\, team coordination\, and toxicity management.\n– Identify challenges in scaling TIL therapy across the NHS \nFind out more details.
URL:https://advancedtherapieswales.co.uk/event/unlocking-til-therapy-a-new-era-for-melanoma-care-in-the-uk/
LOCATION:Midland Hotel\, Manchester
CATEGORIES:Conference
ATTACH;FMTTYPE=image/svg+xml:https://advancedtherapieswales.co.uk/wp-content/uploads/2026/01/Unlocking-TIL.svg
END:VEVENT
END:VCALENDAR